Who Paid My Doc
Gleolan
Drug Prescription
NDC 71469-231-01
General payments
$692,893
Research payments
$1,283,847
Through program year 2024, $692,893 in general payments and $1,283,847 in research payments were reported against Gleolan (Prescription).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $41,915 | 3 |
| 2022 | General | $44,931 | 3 |
| 2022 | Research | $420,897 | 19 |
| 2021 | General | $343,550 | 15 |
| 2021 | Research | $821,035 | 21 |
| 2020 | General | $304,412 | 13 |
Breakdown
Each share is of general payments naming this product in 2022.
Each share is of general payments naming this product to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2022 where a state was reported.
Records
31 general · 43 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.